Augmedix, Inc.
DelistedCIK 1769804fmd_1621QNF0Z8Z5257M3ETPE7XTH2Services · Services-Business Services, NECTemplate: Standard
Coverage: Jan 01, 2019 to Jun 30, 2024, 22 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Total revenues | 14 | 16 | 22 | 31 | 45 |
| Cost of revenue | 9 | 10 | 12 | 17 | 23 |
| Trading and principal transactions revenue | – | – | – | 1 | – |
| Gross profit | 5 | 7 | 10 | 14 | 22 |
| Research and development | 7 | 5 | 7 | 10 | 11 |
| Selling, general and administrative | 14 | 16 | 21 | 26 | 29 |
| Total operating expenses | 21 | 20 | 28 | 36 | 40 |
| Operating income | (17) | (14) | (18) | (22) | (19) |
| Interest expense | 0 | – | 0 | – | – |
| Interest and investment income | 0 | 0 | 0 | 0 | 1 |
| Other non-operating income (expense) | (2) | (2) | 0 | (2) | (0) |
| Income before taxes | – | – | (17) | (24) | (19) |
| Income tax expense | – | – | 0 | 0 | 0 |
| Net income from continuing operations | – | – | (17) | (24) | (19) |
| Net income | (18) | (16) | (17) | (24) | (19) |